0001140361-17-019827.txt : 20170511 0001140361-17-019827.hdr.sgml : 20170511 20170511190647 ACCESSION NUMBER: 0001140361-17-019827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170509 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stonepine Capital Management, LLC CENTRAL INDEX KEY: 0001440771 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 17835891 BUSINESS ADDRESS: STREET 1: 919 NW BOND STREET STREET 2: SUITE 204 CITY: BEND STATE: OR ZIP: 97703 BUSINESS PHONE: 541.647.5664 MAIL ADDRESS: STREET 1: 919 NW BOND STREET STREET 2: SUITE 204 CITY: BEND STATE: OR ZIP: 97703 4 1 doc1.xml FORM 4 X0306 4 2017-05-09 0 0001588972 Recro Pharma, Inc. REPH 0001440771 Stonepine Capital Management, LLC 919 NW BOND STREET SUITE 204 BEND OR 97703 0 0 1 0 Common Stock 2017-05-09 4 S 0 195059 7.6351 D 2461950 I See Notes Common Stock 2017-05-09 4 S 0 33070 7.6351 D 2428880 I See Notes Common Stock 2017-05-10 4 S 0 6412 7.7727 D 2422468 I See Notes Common Stock 2017-05-10 4 S 0 1088 7.7727 D 2421380 I See Notes Common Stock 2017-05-11 4 S 0 7696 7.9647 D 2413684 I See Notes Common Stock 2017-05-11 4 S 0 1304 7.9647 D 2412380 I See Notes The filers (the "Filers") are Stonepine Capital Management, LLC (the "General Partner"), Stonepine Capital, L.P. (the "Partnership"), Jon M. Plexico and Timothy P. Lynch. The General Partner is the general partner and investment adviser of investment funds, including the Partnership (collectively, the "Funds"). Mr. Plexico and Mr. Lynch are the General Partner's managers and control persons. These securities are held directly by the Funds for the benefit of their investors and are indirectly beneficially owned by the General Partner and Mr. Plexico and Mr. Lynch as the General Partner's control persons. The General Partner is filing this Form 4 for itself and the other Filers. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each Filer disclaims beneficial ownership of these securities except to the extent of that Filer's pecuniary interest therein. These securities were sold by the Partnership, which held 2,076,784 shares after the transaction on May 9, 2,070,372 shares after the transaction on May 10 and 2,062,676 shares after the transaction on May 11. These securities were sold by the other Funds. Stonepine Capital Management, LLC, by Timothy P. Lynch, Manager 2017-05-11